We don't just navigate tissue banking regulations.
We write them.

Many countries lack a formal legal framework governing tissue donation, banking, and transplantation. Without it, even the best-intentioned tissue programs cannot operate with confidence. VitaLync works directly with Ministries of Health to draft the legislation and policy frameworks that authorize and govern tissue programs — drawing on US FDA regulations, ISO Standards, AATB Standards, WHO guidelines, and IAEA technical documents as reference frameworks, adapted to each country's legal and cultural context. This includes donor consent laws, tissue traceability requirements, import/export authorization structures, and the establishment of national tissue banking authorities.

Tissue products cannot move across borders without a regulatory pathway on both ends. On the US side, VitaLync operates as an FDA-registered tissue establishment under 21 CFR Part 1271, holding state licenses where required, providing the export certificates, donor traceability documentation, and compliance paperwork that foreign authorities require. On the destination-country side, VitaLync maps the existing import framework — or helps build one where none exists — identifying the correct regulatory authority, documentation requirements, product classification, and approval timelines. For distributors and hospital networks entering new markets, this regulatory roadmapping is the critical first step that determines whether a product can actually reach patients.

For countries establishing their own domestic tissue banking capacity, having a facility is only the beginning. That facility must operate to a standard — and someone must define, document, and assess compliance with that standard. VitaLync provides accreditation consulting based on the country's needs and in alignment with recognized standards, including SOPs for donor evaluation, tissue recovery, processing, storage, and distribution; quality management system design; traceability and documentation requirements; personnel qualification frameworks; and the development of internal audit protocols. For countries seeking to develop an AATB-equivalent national accreditation body, VitaLync can advise on the institutional design of that body itself.

Donor consent is the ethical foundation of every tissue banking program — and its legal requirements vary significantly by country, religion, and cultural context. VitaLync designs consent frameworks that meet international ethical standards while respecting local cultural and religious values, including guidance on presumed consent vs. opt-in models, family authorization structures, culturally adapted consent documentation, and donor family communication protocols. Traceability — the ability to follow a tissue product from donor to recipient — is equally foundational to patient safety and regulatory compliance. VitaLync helps programs design and implement end-to-end traceability systems aligned with both FDA and AATB requirements.

Regulatory frameworks don't pass themselves. Getting tissue banking legislation enacted, or import permits approved, requires sustained engagement with the right government stakeholders — at the right level, with the right framing. VitaLync brings genuine relationships with health ministries across the Middle East, Central Asia, and Latin America, built through years of IAEA consultancy work and direct partnership engagements. We advise on stakeholder mapping, the sequencing of regulatory approvals, how to present programs to ministry decision-makers, and how to navigate the intersection of health policy, procurement authority, and political will. For organizations that have technically sound programs but are struggling to get regulatory traction, this strategic engagement layer is often what makes the difference.

A specialized and often overlooked area of tissue banking, radiation sterilization — using gamma or electron-beam irradiation — allows tissue products to achieve SAL 10⁻⁶ sterility assurance while maintaining biological activity. This is particularly important in markets where cold-chain infrastructure is limited, since radiation-sterilized tissue can often be stored at ambient or controlled room temperature. Valerie's four-year IAEA consultancy focused specifically on this area — advising governments on the technical standards, facility requirements, quality assurance protocols, and regulatory frameworks for radiation-sterilized tissue banking programs. This is a niche that very few consultants can address with genuine hands-on expertise, and it is one of VitaLync's most distinctive service offerings for emerging market tissue programs.